Mimedx market cap MDXG
Share price times shares outstanding: what the whole company sells for, since 2011.
- Today, Nov 2, 2026
- $478.6M
- Highest close in our data
- $1.9B
- Jan 2018
Mimedx is worth $478.6M at the close on Nov 2, 2026, at $3.28 a share.
That is down 57% over the last year and down 49% over five years.
Its highest close in our data was $1.9B in Jan 2018.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $478.6M | $478.6M | $959.7M | −53% |
| 2025 | $1B | $858.1M | $1.4B | −26% |
| 2024 | $1.4B | $838.3M | $1.4B | +36% |
| 2023 | $1B | $364.9M | $1B | +223% |
| 2022 | $316M | $311.3M | $631.4M | −53% |
| 2021 | $677.4M | $661.6M | $1.7B | −33% |
| 2020 | $1B | $353.7M | $1.1B | +25% |
| 2019 | $805M | $227.6M | $822.8M | +383% |
| 2018 | $166.6M | $127.7M | $1.9B | −88% |
| 2017 | $1.4B | $853.1M | $1.9B | +44% |
| 2016 | $970.3M | $738.4M | $1.1B | −5% |
| 2015 | $1B | $792.9M | $1.4B | −15% |
| 2014 | $1.2B | $569.8M | $1.3B | +47% |
| 2013 | $821.9M | $358.3M | $821.9M | +146% |
| 2012 | $334M | $80.3M | $334M | +298% |
| 2011 | $83.9M | $75.1M | $92.1M | n/a |
Against its peers
Companies in Medical - Instruments & Supplies nearest Mimedx's size, closest first, today.
| Company | Market cap |
|---|---|
| MDXGMimedx | $478.6M |
| TCMDTactile Systems Technology | $518.1M |
| EMBCEmbecta | $350.7M |
| MOVMovado | $710.9M |
| INFUInfuSystem | $275.7M |
| IRMDIradimed | $1B |
| UTMDUtah Medical Products | $224.6M |
| IARTIntegra Lifesciences | $1.1B |
| BVSBioventus | $1.1B |
| PDEXPro DEX | $184.5M |
| STAAStaar Surgical | $1.3B |
| Peer median | $614.5M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Mimedx
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.